Gilyazova, I.R.,
Yankina, M.A.,
Kunsbaeva, G.B.,
Klimentova, E.A.,
Izmaylov, A.A.,
V.N. Pavlov,
Khusnutdinova, E.K. (2016) patient. Bioinformatics analysis was conducted and the most significant
mutations in prostate cancer
The goal of the study was to assess the role of concomitant
somatic pathology and calculate
Solovyev, A.V.,
Barashkov, N.A.,
Bady-Khoo, M.S.,
Zytsar, M.V.,
Posukh, O.L.,
Romanov, G.P.,
Rafailov, A.M.,
Sazonov, N.N.,
Alexeev, A.N.,
Dzhemileva, L.U.,
Khusnutdinova, E.K.,
Fedorova, S.A. (2017) The c.-23+1G>A splice site
mutation is one of the most frequent
mutations of gene GJB2 (Cx26, 13q11
Akhmetgaleyevaa, A.F.,
Khidiyatovaa, I.M.,
Saifullinac, E.V.,
Idrisovad, R.F.,
Magzhanov, R.V.,
Khusnutdinovaa, E.K. (2016) in Europeans is HSP
associated with
mutations in the spastin gene (SPG4). Analysis of the gene SPG4 was carried
NIKITIN, A.G.,
CHUDAKOVA, D.A.,
ENIKEEV, R.F.,
GORDIEV, M.G.,
SAKAEVA, D.,
DRUZHKOV, M.,
SHIGAPOVA, L.H.,
BROVKINA, O.I.,
SHAGIMARDANOVA, E.I.,
GUSEV, O.A. (2020) Genome instability—the increased tendency of acquiring
mutations in the genome and ability of a
Nadyrshina, D.,
Zaripova, A.,
Tyurin, A.,
Minniakhmetov, I.,
Zakharova, E.,
Khusainova, R. (2022) in patients from Bashkortostan Republic, Russia. In total, 16
mutations in COL1A1, 11
mutations in COL1A2
Coignard, J.,
Lush, M.,
Beesley, J.,
O’Mara, T.A.,
Dennis, J,
Tyrer, J.P.,
Barnes, D.R.,
McGuffog, L.,
Leslie, G.,
Bolla, M.K.,
Adank, M.A.,
Kiiski, J.I.,
Nevanlinna, H.,
team of authors (2021) Breast cancer (BC) risk for BRCA1 and BRCA2
mutation carriers varies by genetic and familial